Literature DB >> 29588726

Managing Stroke During Transcatheter Aortic Valve Replacement.

Florian Hecker1, Mani Arsalan1, Thomas Walther1.   

Abstract

Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis and an alternative to surgical aortic valve replacement in intermediate-risk patients. There are, however, concerns regarding strokes during TAVR. Reported stroke rates vary strongly depending on the type of study, stroke definition, cohort and study period. Furthermore, stroke after TAVR occurs in three distinct phases: 1) early high-risk, directly procedure related; 2) elevated risk interval between day 2 and day 30; 3) late hazard interval. Each of these phases is caused by the different aetiologies of stroke. This review summarises the different aetiologies and potential strategies for managing stroke during TAVR.

Entities:  

Keywords:  Transcatheter aortic valve replacement; antiplatelet; antithrombotic; embolic protection device; embolisation; transcatheter aortic valve implantation; transient ischaemic attack calcification

Year:  2017        PMID： 29588726      PMCID： PMC5808713          DOI： 10.15420/icr.2016:26:1

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN： 1756-1485


  72 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

Authors:  Neil E Moat; Peter Ludman; Mark A de Belder; Ben Bridgewater; Andrew D Cunningham; Christopher P Young; Martyn Thomas; Jan Kovac; Tom Spyt; Philip A MacCarthy; Olaf Wendler; David Hildick-Smith; Simon W Davies; Uday Trivedi; Daniel J Blackman; Richard D Levy; Stephen J D Brecker; Andreas Baumbach; Tim Daniel; Huon Gray; Michael J Mullen
Journal:  J Am Coll Cardiol       Date:  2011-10-20       Impact factor: 24.094

3.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

4.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

Review 5.  Characterization of neurological injury in transcatheter aortic valve implantation: how clear is the picture?

Authors:  Jonathon P Fanning; Darren L Walters; David G Platts; Eamonn Eeles; Judith Bellapart; John F Fraser
Journal:  Circulation       Date:  2014-01-28       Impact factor: 29.690

6.  Transapical transcatheter aortic valve implantation without prior balloon aortic valvuloplasty: feasible and safe.

Authors:  Lenard Conradi; Moritz Seiffert; Johannes Schirmer; Dietmar Koschyk; Stefan Blankenberg; Hermann Reichenspurner; Patrick Diemert; Hendrik Treede
Journal:  Eur J Cardiothorac Surg       Date:  2013-12-11       Impact factor: 4.191

7.  The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.

Authors:  Thomas G Gleason; John T Schindler; David H Adams; Michael J Reardon; Neal S Kleiman; Louis R Caplan; John V Conte; G Michael Deeb; G Chad Hughes; Sharla Chenoweth; Jeffrey J Popma
Journal:  J Thorac Cardiovasc Surg       Date:  2016-03-12       Impact factor: 5.209

8.  Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging.

Authors:  Alexander Ghanem; Andreas Müller; Claas P Nähle; Justine Kocurek; Nikos Werner; Christoph Hammerstingl; Hans H Schild; Jörg O Schwab; Fritz Mellert; Rolf Fimmers; Georg Nickenig; Daniel Thomas
Journal:  J Am Coll Cardiol       Date:  2010-02-24       Impact factor: 24.094

9.  Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis.

Authors:  Dominique Himbert; Fleur Descoutures; Nawwar Al-Attar; Bernard Iung; Gregory Ducrocq; Delphine Détaint; Eric Brochet; David Messika-Zeitoun; Fady Francis; Hassan Ibrahim; Patrick Nataf; Alec Vahanian
Journal:  J Am Coll Cardiol       Date:  2009-07-21       Impact factor: 24.094

10.  Incidence and Clinical Impact of Stroke Complicating Transcatheter Aortic Valve Implantation: Results From the German TAVI Registry.

Authors:  Nicolas Werner; Uwe Zeymer; Steffen Schneider; Timm Bauer; Ulrich Gerckens; Axel Linke; Christian Hamm; Horst Sievert; Holger Eggebrecht; Ralf Zahn
Journal:  Catheter Cardiovasc Interv       Date:  2016-06-03       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.